SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-094214
Filing Date
2018-03-23
Accepted
2018-03-23 16:35:55
Documents
5
Effectiveness Date
2018-03-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A d508629ddefa14a.htm DEFA14A 26436
2 GRAPHIC g508629img004.jpg GRAPHIC 164130
3 GRAPHIC g508629img005.jpg GRAPHIC 208657
4 GRAPHIC g508629img006.jpg GRAPHIC 71508
5 GRAPHIC g508629img007.jpg GRAPHIC 74592
  Complete submission text file 0001193125-18-094214.txt   731783
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36329 | Film No.: 18710531
SIC: 2834 Pharmaceutical Preparations